Cargando…
Application of Bayesian approaches in drug development: starting a virtuous cycle
The pharmaceutical industry and its global regulators have routinely used frequentist statistical methods, such as null hypothesis significance testing and p values, for evaluation and approval of new treatments. The clinical drug development process, however, with its accumulation of data over time...
Autores principales: | Ruberg, Stephen J., Beckers, Francois, Hemmings, Rob, Honig, Peter, Irony, Telba, LaVange, Lisa, Lieberman, Grazyna, Mayne, James, Moscicki, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931171/ https://www.ncbi.nlm.nih.gov/pubmed/36792750 http://dx.doi.org/10.1038/s41573-023-00638-0 |
Ejemplares similares
-
The Virtuous Cycle of a Data Ecosystem
por: Voytek, Bradley
Publicado: (2016) -
Bayesian Statistics for Medical Devices: Progress Since 2010
por: Campbell, Gregory, et al.
Publicado: (2023) -
Hypertension and atrial fibrillation: Closing a virtuous circle
por: Gue, Ying X., et al.
Publicado: (2021) -
Virtuous Journalism
Publicado: (1888) -
Virtuous victims
por: Jordan, Jillian J., et al.
Publicado: (2021)